Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience

José A. del Campo*, Manuel Parra-Sánchez, Blanca Figueruela, Silvia García-Rey, Josep Quer, Josep Gregori, Samuel Bernal, Lourdes Grande, José C. Palomares, Manuel Romero-Gómez

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículoInvestigaciónrevisión exhaustiva

23 Citas (Scopus)

Resumen

Background The effectiveness of the new generation of hepatitis C treatments named direct-acting antiviral agents (DAAs) depends on the genotype, subtype, and resistance-associated substitutions present in individual patients. The aim of this study was to evaluate a massive sequencing platform for the analysis of genotypes and subtypes of hepatitis C virus (HCV) in order to optimize therapy. Methods A total of 84 patients with hepatitis C were analyzed. The routine genotyping methodology for HCV used at the study institution (Versant HCV Assay, LiPA) was compared with a deep sequencing platform (454/GS-Junior and Illumina MiSeq). Results The mean viral load in these HCV patients was 6.89 × 106 ± 7.02 × 105. Viral genotypes analyzed by LiPA were distributed as follows: 26% genotype 1a (22/84), 55% genotype 1b (46/84), 1% genotype 1 (1/84), 2.5% genotype 3 (2/84), 6% genotype 3a (5/84), 6% genotype 4a/c/d (5/84). When analyzed by deep sequencing, the samples were distributed as follows: 27% genotype 1a (23/84), 56% genotype 1b (47/84), 8% genotype 3a (7/84), 5% genotype 4d (4/84), 2.5% genotype 4f (2/84). Six of the 84 patients (7%) were infected with more than one subtype. Among these, 33% (2/6) failed DAA-based triple therapy. Conclusions The detection of mixed infection could explain some treatment failures. Accurate determination of viral genotypes and subtypes would allow optimal patient management and improve the effectiveness of DAA therapy.

Idioma originalInglés
Páginas (desde-hasta)114-117
Número de páginas4
PublicaciónInternational Journal of Infectious Diseases
Volumen67
DOI
EstadoPublicada - feb 2018

Huella

Profundice en los temas de investigación de 'Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience'. En conjunto forman una huella única.

Citar esto